Titan Pharmaceuticals
TTNP
#10396
Rank
ยฃ4.48 M
Marketcap
ยฃ3.37
Share price
-3.76%
Change (1 day)
27.41%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -ยฃ3.38

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ3.21. In 2023 the company made an earnings per share (EPS) of -ยฃ5.41 an increase over its 2022 EPS that were of -ยฃ11.10.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ3.38
2023-ยฃ5.41-51.22%
2022-ยฃ11.10-15.61%
2021-ยฃ13.15-81.37%
2020-ยฃ70.59-77.52%
2019-ยฃ314.06-56.32%
2018-ยฃ719.04-59.51%
2017-ยฃ1,776-371.81%
2016ยฃ653.40-144.35%
2015-ยฃ1,473300%
2014-ยฃ368.29-121.54%
2013ยฃ1,710-151.38%
2012-ยฃ3,328-11.54%
2011-ยฃ3,762188.89%
2010-ยฃ1,302-10%
2009-ยฃ1,447
2007-ยฃ5,932-2.38%
2006-ยฃ6,077-39.13%
2005-ยฃ9,983-16.87%
2004-ยฃ12,009-22.43%
2003-ยฃ15,4814.9%
2002-ยฃ14,75861.9%
2001-ยฃ9,115-13.7%
2000-ยฃ10,56265.01%
1999-ยฃ6,401-35.87%
1998-ยฃ9,981-1824.71%
1997ยฃ578.74-102.4%
1996-ยฃ24,162

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ7.63-337.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.38-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-ยฃ1.04-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
ยฃ0.02192-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ0.18-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ2.47-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA